HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

FAA Approves Invacare XPO2

January 22, 2009 by HME Business

The Federal Aviation Administration has approved Invacare Corp.’s XPO2 portable oxygen concentrator for use on board passenger aircraft.

Now that the XPO2,, which first debuted in May 2008, has been approved by the FAA, Invacare says it will approach individual airlines for their approvals regarding in-flight use of oxygen systems.  Southwest Airlines has already approved the system.

“Now that the XPO2 has FAA approval, we will meet an even greater variety of patient needs,” said Joseph Lewarski, vice president, Invacare respiratory division.

In terms of traveling capabilities, the XPO2 weighs six pounds, and incorporates Sensi-Pulse technology, a five-setting pulse dose oxygen delivery system that keeps oxygen patients saturated during all activities of daily living. The POC operates from battery, AC or DC power. The two-and-a-half hour battery duration (at setting 2) can be doubled to five hours through the use of an optional one-and-a-half pound supplemental battery that attaches to the carrying case.

Other features include quiet, simple operation, and a contemporary, non-medical look.

Related Articles Read More >

AAHomecare: Competitive Bidding Won’t Feature ‘Legacy’ Product Categories
CQRC ‘Commends’ Exclusions of Supplemental Oxygen, CPAP from Medicare Competitive Bidding
The Council for Quality Respiratory Care also urged industry support for the SOAR act.
AOPA: Final Rule to Have ‘Significant Impact’ on Orthotics, Prosthetics Providers
OTS knee, spinal and upper-extremity orthoses are included in the remote item delivery portion of the competitive bidding program.
Resmed Announces FDA Clearance for AI Device to Support Sleep Therapy Regimens
The device incorporates artificial intelligence and will be marketed as Smart Comfort.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe